- Research works
- 23 ▼ 80% vs 2013–17
- Citations
- 1.2k 53.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 20% world 28%
Not ranked overall: Trevigen is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Trevigen?
By fractional works in all years, weighted toward what it does more of than the world: Regenerative Medicine, Extracellular Matrix, Immunotherapy, Tissue Engineering, Cancer Stem Cells, Tumor Metastasis, Cancer and Biosensors.
- DNA nanotechnology
- Arginine Deprivation
- Tumor Regression
- Microfluidic Devices
- Decellularization
- Bioprinting
- Gene Therapy
- Biosensors
- Nanoparticles
- Cancer Stem Cells
- Cancer
- Extracellular Matrix
- Regenerative Medicine
- Immunotherapy
- Tissue Engineering
- Tumor Metastasis
- Angiogenesis
- Cell Culture
- Tumor Targeting
- DNA Damage
- Homologous Recombination
- Organ Engineering
- Gene Expression
- Bacterial Therapy
- Self-Assembly
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Regenerative Medicine3▲ 54×3 topics
- Extracellular Matrix3▲ 46×3 topics
- Immunotherapy2▲ 14×5 topics
- Cancer2▲ 6.1×5 topics
- Tissue Engineering2▲ 16×4 topics
- Cancer Stem Cells2▲ 191×1 topic
- Tumor Metastasis2▲ 137×1 topic
- Nanoparticles2▲ 5.3×3 topics
- Angiogenesis1▲ 15×4 topics
- Biosensors1▲ 11×2 topics
- Cell Culture1▲ 54×2 topics
- Gene Therapy1▲ 23×2 topics
- Tumor Targeting1▲ 46×2 topics
- Bioprinting1▲ 120×1 topic
- DNA Damage1▲ 41×3 topics
- Decellularization1▲ 147×1 topic
- Homologous Recombination1▲ 83×2 topics
- Microfluidic Devices1▲ 66×1 topic
- Organ Engineering1▲ 147×1 topic
- Tumor Regression1▲ 67×2 topics
- Gene Expression1▲ 8.4×4 topics
- Arginine Deprivation1▲ 105×1 topic
- Bacterial Therapy1▲ 105×1 topic
- DNA nanotechnology1▲ 47×1 topic
- Self-Assembly1▲ 12×1 topic
Which research topics does Trevigen publish most on?
By volume in 2022–2025: Immunotherapy and Immune Responses, Cancer Research and Treatments, Glycosylation and Glycoproteins Research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 0 works
- 2 Cancer Research and Treatments Biotechnology 0 works
- 3 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 4 CAR-T cell therapy research Oncology 0 works
- 5 HER2/EGFR in Cancer Research Oncology 0 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Trevigen's research output changed?
Output in 2018–2022 was 80% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- NIST Center for Neutron Research
- Material Measurement Laboratory
- Center for Nanoscale Science and Technology
- Information Technology Laboratory
- Robotic Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.